healthtech-logo
Submit Press Release
  • News
  • Resources
    • Newsletter
  • Insights
    • Interviews
    • Featured Articles
    • Guest Posts
  • Contact
  • News
  • Resources
    • Newsletter
  • Insights
    • Interviews
    • Featured Articles
    • Guest Posts
  • Contact
Advertise with us
Submit Press Release

RIS Rx Appoints John Driscoll as Chairman of the Board

Read More »
October 15, 2025

Safecor Health Grows Team to Boost Support and Growth

Read More »
October 15, 2025

Mission Therapeutics Raises $13.3 Million for Parkinson’s Drug Trials

Read More »
October 15, 2025

Inovalon Partners with DoseMe for Precision Dosing in Pharmacy

Read More »
October 14, 2025

First Patient Treated With Leqembi (lecanemab) in the Nordics

Read More »
October 14, 2025

OSR Holdings to Acquire Woori IO for Diabetes Technology

Read More »
October 14, 2025

AAVantgarde Gains FDA Orphan Status for Stargardt Drug

Read More »
October 2, 2025

KalVista Pharmaceuticals Appoints Bethany L. Sensenig to Board

Read More »
October 2, 2025

DataJoint Raises $4.9 Million to Transform Data Management in Science

Read More »
October 1, 2025
Biocon Sets U.S. Launch Date for Denosumab Biosimilars

Biocon Sets U.S. Launch Date for Denosumab Biosimilars

Read More »
October 1, 2025
Halozyme to Acquire Elektrofi for Drug Delivery Expansion

Halozyme to Acquire Elektrofi for Drug Delivery Expansion

Read More »
October 1, 2025
Middlesex Hospital, Clearway Open First Specialty Pharmacy

Middlesex Hospital, Clearway Open First Specialty Pharmacy

Read More »
September 30, 2025
Load More

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 26 November 2025

FluidAI Medical Announces an Acquisition Deal With Emmetros Limited

Healgen Highlights Rapid Check Test for COVID-19 and Flu Season

Alleva Earns ONC Certification, SOC 2, and HIPAA Compliance

Tangram Therapeutics Files CTA for TGM-312 Phase 1/2 Study

Tangram Therapeutics Files CTA for TGM-312 Phase 1/2 Study

Herantis Pharma Announces Successful Completion of Six-Month Glp Toxicology Study of Her-096

Herantis Pharma Announces Successful Completion of Six-Month Glp Toxicology Study of Her-096

Fuel up with free Health Tech Insights

Quick Links

  • About
  • News
  • Newsletter
  • Write for Us

Insights

  • Interviews
  • Articles
  • Guest Post

Get in touch

  • Do Not Sell My Information
  • Privacy Policy
  • Contact Us

Follow Us

  • Linkedin Linkedin
Our Other Brands
Intenttech Martech Cybertech Fintech Hrtech Aitech contactcenter

Copyright © 2025  All Rights Reserved. Health Technology Insights. An Intent Amplify® Product.